Wednesday, July 9, 2014

Gene Variants may Predict Cancer Patients' Risk for Radiation-induced Toxicity

A new study has found how key genetic variants could affect how cancer patients respond to radiation treatment. The research team, which included researchers at the Icahn School of Medicine at Mount Sinai, found that variations in the TANC1 gene are associated with a greater risk for radiation-driven side effects in prostate cancer patients, which include incontinence, impotence and diarrhea. The current results are based on a genome-wide association study, a ...

Read More

No comments:

Post a Comment